Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Arcutis Biotherapeutics Inc.
Director
Stevanato Group S.p.A.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Arcutis Biotherapeutics Inc. | Open-market sale | −4,946 | $24.38 | $120,583 |
| Jun 12, 2026 | Stevanato Group S.p.A. | Grant or award | +4,975 | — | — |
| Jun 5, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +5,778 | — | — |
| Nov 24, 2025 | Arcutis Biotherapeutics Inc. | Option exercise | +18,052 | $8.63 | $155,789 |
| Nov 24, 2025 | Arcutis Biotherapeutics Inc. | Option exercise | +7,220 | $7.51 | $54,222 |
| Nov 24, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −25,272 | $30.78 | $777,872 |
| Jun 12, 2025 | Arcutis Biotherapeutics Inc. | Grant or award | +7,609 | — | — |
| Jun 14, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +10,139 | — | — |
| May 31, 2023 | Arcutis Biotherapeutics Inc. | Grant or award | +4,375 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.